A multicentre validation study of the diagnostic value of plasma neurofilament lightNicholas J. Ashton, Oskar Hansson, André Strydom et al.|Nature Communications|2021Cited by 554
CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Olivier Bousiges, Ulf Andréasson et al.|Alzheimer s & Dementia|2013Cited by 386
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s diseaseJuan Fortea, Víctor Montal, Jordi Pegueroles et al.|Nature Medicine|2024Cited by 333
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal FluidAlberto Lleó, Olivia Belbin|Molecular & Cellular Proteomics|2019Cited by 252
Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsBetty M. Tijms, Pieter Jelle Visser, Johan Gobom et al.|Brain|2020Cited by 221